Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment. - Wikidata - awgldk - TriplyDB

Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment.

Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment.

http://www.wikidata.org/entity/Q37629184

about

Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo

P2860

Q55370734-42007B95-1C8F-41D3-8AB7-F59FFC026781

P2860

Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment.

http://www.wikidata.org/entity/Q37629184

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Percutaneous Coronary Interven ...... r Bare-Metal Stent Deployment.

@en

Percutaneous Coronary Interven ...... r Bare-Metal Stent Deployment.

@nl

type

label

Percutaneous Coronary Interven ...... r Bare-Metal Stent Deployment.

@en

Percutaneous Coronary Interven ...... r Bare-Metal Stent Deployment.

@nl

prefLabel

Percutaneous Coronary Interven ...... r Bare-Metal Stent Deployment.

@en

Percutaneous Coronary Interven ...... r Bare-Metal Stent Deployment.

@nl

P1433

Q37629184-951FFA6E-8026-430F-97A9-E3E0DE7E0C71

P1476

Q37629184-1DF81C81-68F6-4700-922A-9E22C7FDFBDB

P2093

Q37629184-0F2B8FDC-122D-44EB-BCBC-251F791D3F5F

Q37629184-3ACB345A-9A5E-43E8-8CC5-E6684EF6FCB9

Q37629184-C0E86ECF-8485-4051-BB34-AAC184CB8851

Q37629184-C3CD6923-D98C-4300-AE8B-57C615654A1D

Q37629184-E47059F1-6C02-410E-B6DA-CC0D43BB675C

P2860

Q37629184-0C06EBA2-6994-454B-A72E-162C49A22902

Q37629184-1A268A60-1B22-477E-B732-19812629E923

Q37629184-236352E2-5FC7-434A-AFA2-980A0D303610

Q37629184-2B43A1A1-161F-4F86-B345-1AE48B67CE3E

Q37629184-3DE942B8-48AB-42F5-A87B-2194A7423433

Q37629184-4759C92E-E22A-41CA-9F6D-44EB12C7A49D

Q37629184-627AEC37-D94A-488C-9AE2-592ABC74DDF3

Q37629184-640AE742-AE54-4155-87AF-9771CFD64175

Q37629184-69AFFAF2-CBED-4A5A-80E9-E5372CE5B55F

Q37629184-6EAE9626-BF10-48DE-9B90-D911615C5465

P304

Q37629184-988AF038-8FC2-441C-81E1-D38EE3C76F68

P31

Q37629184-EFCADCCC-AA2E-4CFD-BAE3-29DD2B32E23D

P356

Q37629184-E50BDC05-C73B-41A9-8B1A-28DE546F2C94

P433

Q37629184-C308120E-333B-4E1F-89BB-002B6746448B

P478

Q37629184-2ED53102-9106-49FD-8CEE-9F04F0AB5A54

P577

Q37629184-4309965B-2CF9-494F-86BC-5B3895A97D17

P698

Q37629184-015E8F0E-438A-45EA-BE2F-8FC295CC0EFF

P932

Q37629184-81A4D2DC-51A9-4A70-8B10-25FDFF09A6CD

P356

P1433

Cardiology research

P1476

Percutaneous Coronary Interven ...... r Bare-Metal Stent Deployment.

@en

P2093

Dinaldo C Oliveira

http://www.w3.org/2001/XMLSchema#string

Emanuel Sarinho

http://www.w3.org/2001/XMLSchema#string

Emmanuele Tenorio

http://www.w3.org/2001/XMLSchema#string

Norma Brito

http://www.w3.org/2001/XMLSchema#string

Viviane Gouveia

http://www.w3.org/2001/XMLSchema#string

P2860

Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery

Outcomes and complications associated with off-label and untested use of drug-eluting stents

Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis

Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model

Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial).

A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications.

OPTIMA Tacrolimus-eluting Stent: A Twelve-month Clinical Follow up with Two Different Periods of Dual Antiplatelet Therapy; 2-month vs. 6-month Approach

In-stent restenosis in the drug-eluting stent era.

P304

104-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/CR468W

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28197276

http://www.w3.org/2001/XMLSchema#string

P932

5295516

http://www.w3.org/2001/XMLSchema#string